Skip to main content
Log in

Tick-tock, beat the clock: comparative analysis of disc diffusion testing with 6-, 10-, and 24-h growth for accelerated antimicrobial susceptibility testing and antimicrobial stewardship

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Disc diffusion testing by Kirby-Bauer technique is the most used method for determining antimicrobial susceptibility in microbiological laboratories. The current guidelines by The Clinical and Laboratory Standards Institute (CLSI) 2022 specify using an 18- to 24-h growth for testing by disc diffusion. We aim to determine if using an early growth (6 h and 10 h) would produce comparable results, thus ultimately leading to reduced turnaround time. Six-hour, 10-h, and 24-h growths of 20 quality control strains and 6-h and 24-h growths of 48 clinical samples were used to perform disc diffusion testing using a panel of appropriate antimicrobial agents. Disc diffusion zone sizes were interpreted for all and comparative analyses were performed to determine categorical agreement, minor errors (mE), major errors (ME), and very major errors (VME) according to CLSI guidelines. On comparing with the standard 24 h of incubation, disc diffusion from 6-h and 10-h growths of quality control strains showed 94.38% categorical agreement, 5.10% mE, 0.69% MEs, and no VMEs. Disc diffusion testing for the additional 40 clinical samples yielded a similarly high level of categorical agreement (98.15%) and mE, ME, and VME of 1.29%, 1.22%, and 0% respectively. Disc diffusion testing using early growth is a simple and accurate method for susceptibility testing that can reduce turnaround time and may prove to be critical for timely patient management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article.

Code availability

Not applicable.

References

  1. Bauer AW, Kirby WMM, Sherris JC et al (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496

    Article  CAS  PubMed  Google Scholar 

  2. Clinical and Laboratory Standards Institute (2022) Performance standards for antimicrobial susceptibility testing M100, 32nd edn. CLSI, Wayne, PA, USA

    Google Scholar 

  3. Food and Drug Administration (2017) 21st Century Cures Act: announcing the establishment of the Susceptibility Test Interpretive Criteria Website. Fed Regist 82:58617–58618

    Google Scholar 

  4. Humphries RM, Ferraro MJ, Hindler JA (2018) Impact of 21st Century Cures Act on breakpoints and commercial antimicrobial susceptibility test systems: progress and pitfalls. J Clin Microbiol 56:e201800139-18. https://doi.org/10.1128/JCM.00139-18

    Article  Google Scholar 

  5. Humphries RM, Hindler JA (2016) Emerging resistance, new antimicrobial agents. . . but no tests! The challenge of antimicrobial susceptibility testing in the current US regulatory landscape. Clin Infect Dis 63:83–88. https://doi.org/10.1093/cid/ciw201

    Article  CAS  PubMed  Google Scholar 

  6. Clinical and Laboratory Standards Institute (2015) Performance standards for antimicrobial disc susceptibility testing M02–A12. CLSI, Wayne, PA, USA

    Google Scholar 

  7. Webber DM, Wallace MA, Burnham CA (2022) Stop waiting for tomorrow: disk diffusion performed on early growth is an accurate method for antimicrobial susceptibility testing with reduced turnaround time. J Clin Microbiol 60(5):e03007-e3020. https://doi.org/10.1128/JCM.03007-20

    Article  PubMed  PubMed Central  Google Scholar 

  8. Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376:2235–2244. https://doi.org/10.1056/NEJMoa1703058

    Article  PubMed  PubMed Central  Google Scholar 

  9. CLSI Clinical and Laboratory Standards Institute (2008) Development of in-vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd edn. CLSI, Wayne PA, USA

    Google Scholar 

  10. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596

    Article  PubMed  Google Scholar 

  11. Humphries R (2020) Update on susceptibility testing: genotypic and phenotypic methods. Clin Lab Med 40:433–446. https://doi.org/10.1016/j.cll.2020.08.002

    Article  PubMed  Google Scholar 

  12. Dubourg G, Lamy B, Ruimy R (2018) Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result. Clin Microbiol Infect 24(9):935–943. https://doi.org/10.1016/j.cmi.2018.03.031

    Article  CAS  PubMed  Google Scholar 

  13. Donghui S, Yu L (2021) Mini-review: Recent advances in imaging-based rapid antibiotic susceptibility testing. Sensors Actuators Rep 3:100053. https://doi.org/10.1016/j.snr.2021.100053. (ISSN 2666-0539)

    Article  Google Scholar 

  14. Foudraine DE, Dekker LJM, Strepis N, Nispeling SJ, Raaphorst MN, Kloezen W, Colle P, Verbon A, Klaassen CHW, Luider TM, Goessens WHF (2022) Using targeted liquid chromatography-tandem mass spectrometry to rapidly detect β-lactam, aminoglycoside, and fluoroquinolone resistance mechanisms in blood cultures growing E. coli or K. pneumoniae. Front Microbiol 13:887420. https://doi.org/10.3389/fmicb.2022.887420

    Article  PubMed  PubMed Central  Google Scholar 

  15. Cenci E, Paggi R, Socio GV, Bozza S, Camilloni B, Pietrella D, Mencacci A (2020) Accelerate Pheno™ blood culture detection system: a literature review. Future Microbiol 15:1595–1605. https://doi.org/10.2217/fmb-2020-0177

    Article  CAS  PubMed  Google Scholar 

  16. Filbrun AB, Richardson JC, Khanal PC, Tzeng YL, Dickson RM (2022) Rapid, label-free antibiotic susceptibility determined directly from positive blood culture. Cytometry A 101(7):564–576. https://doi.org/10.1002/cyto.a.24560

    Article  CAS  PubMed  Google Scholar 

  17. Nix ID, Idelevich EA, Storck LM, Sparbier K, Drews O, Kostrzewa M, Becker K (2020) Detection of methicillin resistance in Staphylococcus aureus from agar cultures and directly from positive blood cultures using MALDI-TOF mass spectrometry-based direct-on-target microdroplet growth assay. Front Microbiol 14(11):232. https://doi.org/10.3389/fmicb.2020.00232

    Article  Google Scholar 

  18. Durand C, Boudet A, Lavigne JP, Pantel A (2020) Evaluation of two methods for the detection of third generation cephalosporins resistant Enterobacterales directly from positive blood cultures. Front Cell Infect Microbiol 11(10):491. https://doi.org/10.3389/fcimb.2020.00491

    Article  CAS  Google Scholar 

  19. Stupar P, Opota O, Longo G, Prod’hom G, Dietler G, Greub G et al (2017) Nanomechanical sensor applied to blood culture pellets: a fast approach to determine the antibiotic susceptibility against agents of bloodstream infections. Clin Microbiol Infect 23:400e5

    Article  Google Scholar 

  20. Idelevich EA, Schule I, Grunastel B, Wullenweber J, Peters G, Becker K (2014) Acceleration of antimicrobial susceptibility testing of positive blood cultures by inoculation of Vitek 2 cards with briefly incubated solid medium cultures. J Clin Microbiol 52:4058e62

    Article  Google Scholar 

  21. Le Page S, Raoult D, Rolain JM (2015) Real-time video imaging as a new and rapid tool for antibiotic susceptibility testing by the disc diffusion method: a paradigm for evaluating resistance to imipenem and identifying extended- spectrum beta-lactamases. Int J Antimicrob Agents 45:61e5

    Google Scholar 

  22. Chandrasekaran S, Abbott A, Campeau S et al (2018) Direct-from-blood-culture disk diffusion to determine antimicrobial susceptibility of Gram-negative bacteria: preliminary report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group. J Clin Microbiol 56:e01678-e1717. https://doi.org/10.1128/JCM.01678-17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Jonasson E, Matuschek E, Kahlmeter G (2020) The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother 75:968–978. https://doi.org/10.1093/jac/dkz548

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Åkerlund A, Jonasson E, Matuschek E et al (2020) EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother 75:3230–3238. https://doi.org/10.1093/jac/dkaa333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Åkerlund A, Jonasson E, Matuschek E, Serrander L, Sundqvist M, Kahlmeter G, the RAST Study Group (2020) EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother 75(11):3230–3238. https://doi.org/10.1093/jac/dkaa333

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Fitzgerald C, Stapleton P, Phelan E, Mulhare P, Carey B, Hickey M, Lynch B, Doyle M (2016) Rapid identification and antimicrobial susceptibility testing of positive blood cultures using MALDI-TOF MS and a modification of the standardised disc diffusion test: a pilot study. J Clin Pathol. jclinpath2015–203436. https://doi.org/10.1136/jclinpath-2015-203436

  27. Humphries RM et al (2018) The continued value of disk diffusion for assessing antimicrobial susceptibility in clinical laboratories: report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group. J Clin Microbiol 56:e00437-e518. https://doi.org/10.1128/JCM.00437-18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank our colleagues from the Department of Microbiology, All India Institute of Medical Sciences, New Delhi, for their insight and guidance. We would also like to thank Dr. Maroof Ahmad Khan for his advice on statistical analysis.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by Dr. Kavi Priya Appasami and Dr. Jaya Biswas. The first draft of the manuscript was written by Dr. Kavi Priya Appasami and Dr. Jaya Biswas and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hitender Gautam.

Ethics declarations

Ethics approval

This study involved the use of quality control strains and established clinical isolates. The AIIMS Research Ethics Committee has confirmed that no ethical approval is required.

Consent to participate

Not applicable as this study involved the use of quality control strains and established clinical isolates.

Consent for publication

Not applicable as no confidential patient information has been included in the manuscript.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biswas, J., Appasami, K.P., Gautam, H. et al. Tick-tock, beat the clock: comparative analysis of disc diffusion testing with 6-, 10-, and 24-h growth for accelerated antimicrobial susceptibility testing and antimicrobial stewardship. Eur J Clin Microbiol Infect Dis 42, 929–943 (2023). https://doi.org/10.1007/s10096-023-04611-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-023-04611-y

Keywords

Navigation